Published in Drug Week, October 1st, 2004
The results were outlined in a paper presented by Dr. Dan Barouch of Harvard Medical School and the Beth Israel Deaconess Medical Center to the AIDS Vaccine 2004 conference in Lausanne, Switzerland.
Barouch reported results concerning the potency of adenovirus serotypes 11 and 35 (rAd11 and rAd35) when combined with antigens of simian immunodeficiency virus, a virus that causes AIDS-like symptoms in monkeys. The results showed both recombinant serotypes were extremely effective in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.